Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Varma

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2013
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyondHugh A Barton, Yurong Lai, Theunis C Goosen, et al.
Cancer|February 1, 1994
A new fiducial alignment system to overlay abdominal computed tomography or magnetic resonance anatomical images with radiolabeled antibody single-photon emission computed tomographic scansY E Erdi, B W Wessels, R DeJager, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 19, 2016
The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced MyopathyHeather Eng, Renato J Scialis, Charles J Rotter, et al.
Heliyon|February 29, 2024
Investigation on effect of cerium oxide additive in waste plastic oil fueled CI engineU Ulagarjun, Varun V Varma, Abhijith K Menon, et al.
Transplantation|November 26, 1997
Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survivalP A Sheiner, C V Varma, J V Guarrera, et al.
Molecular Pharmaceutics|June 30, 2011
pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1Manthena V Varma, Charles J Rotter, Jonathan Chupka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 16, 2014
Toward a unified model of passive drug permeation II: the physiochemical determinants of unbound tissue distribution with applications to the design of hepatoselective glucokinase activatorsAvijit Ghosh, Tristan S Maurer, John Litchfield, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2018
Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus MonkeyRachel E Kosa, Sarah Lazzaro, Yi-An Bi, et al.
Clinical Pharmacology and Therapeutics|September 21, 2016
Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of MontelukastM V Varma, E Kimoto, R Scialis, et al.
Molecular Pharmaceutics|April 12, 2012
pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discoveryManthena V Varma, Iain Gardner, Stefanus J Steyn, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Expert Opinion on Drug Metabolism & Toxicology|January 22, 2013
Model-based approaches to predict drug-drug interactions associated with hepatic uptake transporters: preclinical, clinical and beyondHugh A Barton, Yurong Lai, Theunis C Goosen, et al.
Cancer|February 1, 1994
A new fiducial alignment system to overlay abdominal computed tomography or magnetic resonance anatomical images with radiolabeled antibody single-photon emission computed tomographic scansY E Erdi, B W Wessels, R DeJager, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 19, 2016
The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced MyopathyHeather Eng, Renato J Scialis, Charles J Rotter, et al.
Heliyon|February 29, 2024
Investigation on effect of cerium oxide additive in waste plastic oil fueled CI engineU Ulagarjun, Varun V Varma, Abhijith K Menon, et al.
Transplantation|November 26, 1997
Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survivalP A Sheiner, C V Varma, J V Guarrera, et al.
Molecular Pharmaceutics|June 30, 2011
pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1Manthena V Varma, Charles J Rotter, Jonathan Chupka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 16, 2014
Toward a unified model of passive drug permeation II: the physiochemical determinants of unbound tissue distribution with applications to the design of hepatoselective glucokinase activatorsAvijit Ghosh, Tristan S Maurer, John Litchfield, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2018
Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus MonkeyRachel E Kosa, Sarah Lazzaro, Yi-An Bi, et al.
Clinical Pharmacology and Therapeutics|September 21, 2016
Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of MontelukastM V Varma, E Kimoto, R Scialis, et al.
Molecular Pharmaceutics|April 12, 2012
pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discoveryManthena V Varma, Iain Gardner, Stefanus J Steyn, et al.
Pageof 10